activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304–1309. 55. Ruderman NB, Cacicedo JM, Itani S, Yagihashi N, Saha AK, et al. (2003) Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans 31: 202–206. 56. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, et al. (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 277: 32571–32577. 57. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, et al. (2001) Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II- induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888–894. AMPK-Dependent Angiogenesis by Nitrated Lipids 58. Davis BJ, Xie Z, Viollet B, Zou MH (2006) Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55: 496–505. 59. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J (1999) PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 19: 546–551. 60. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WGt, et al. (2004) Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 279: 43940–43951. PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e31056